Avanos Medical (AVNS) Total Current Liabilities (2013 - 2026)

Avanos Medical has disclosed Total Current Liabilities across 14 years of filings, most recently posting $131.2 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $131.2 million, down 4.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $131.2 million (down 4.37% YoY), and the FY2025 annual result was $165.2 million, changed 0.42% from the prior year.
• Total Current Liabilities came in at $131.2 million for Q1 2026 at Avanos Medical, down from $165.2 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $234.6 million in Q4 2023 to a low of $131.2 million in Q1 2026.
• The 5-year median for Total Current Liabilities is $162.3 million (2022), against an average of $170.0 million.
• Across the five-year window, Total Current Liabilities surged 37.21% in 2022 and plunged 35.35% in 2025, its largest moves.
• Avanos Medical's Total Current Liabilities stood at $191.0 million in 2022, then advanced by 22.83% to $234.6 million in 2023, then dropped by 29.28% to $165.9 million in 2024, then slipped by 0.42% to $165.2 million in 2025, then retreated by 20.58% to $131.2 million in 2026.
• The last three Total Current Liabilities figures came in at $131.2 million (Q1 2026), $165.2 million (Q4 2025), and $147.9 million (Q3 2025), per Business Quant data.